[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-353668-105":59,"doc-detail-353668-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","clinical-utility-of-ogn-in-pan-cancer-diagnostic-biomarker-and-immune-microenvironment-regulator","Clinical utility of OGN in pan-cancer - diagnostic biomarker and immune microenvironment regulator","","Osteoglycin (OGN), an extracellular matrix protein with incompletely defined oncologic roles, is evaluated across cancers to clarify expression patterns, clinical relevance, immune interactions, and underlying mechanisms. Integrated multi-omics analyses combine GTEx, CCLE, TCGA, and HPA to assess differential expression, diagnostic performance via ROC/AUC, and prognosis using Kaplan-Meier and Cox models. Immune microenvironment associations are quantified with ESTIMATE, CIBERSORT, and enrichment approaches, linking OGN to immune infiltration, PD-L1, MSI, TMB, and key signaling pathways.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-utility-of-ogn-in-pan-cancer-diagnostic-biomarker-and-immune-microenvironment-regulator/353668/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-utility-of-ogn-in-pan-cancer-diagnostic-biomarker-and-immune-microenvironment-regulator/353668.png","ImageObject",300,407,{"name":92,"@type":93},"Liam","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-15","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the study aim regarding OGN in pan-cancer?","Question",{"text":113,"@type":114},"To determine OGN expression patterns across cancers, evaluate diagnostic and prognostic utility, and characterize immune microenvironment interactions and functional mechanisms.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How is OGN diagnostic performance assessed?",{"text":118,"@type":114},"Diagnostic utility is evaluated using the area under the ROC curve (AUC), comparing normal tissues with tumor samples.",{"name":120,"@type":111,"acceptedAnswer":121},"What immune-related features are associated with high OGN expression?",{"text":122,"@type":114},"High OGN expression correlates with immune cell infiltration, chemokine signaling, PD-L1 levels, microsatellite instability (MSI), and tumor mutation burden (TMB).","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},353668,1790198280,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},8796095461564,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Original Article  \nClinical utility of OGN in pan-cancer: diagnostic biomarker and immune microenvironment regulator  \nXiaoyan Chen1\\#, Xue Wang2\\#, Jian Peng3  \n1Department of Cancer Medical Center, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China; 2State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; 3Anhui Institute of Pediatric Research, Anhui Provincial Children’s Hospital, Hefei, China  \nContributions: (I) Conception and design: J Peng; (II) Administrative support: X Wang; (III) Provision of study materials or patients: X Chen; (IV) Collection and assembly of data: X Chen, J Peng; (V) Data analysis and interpretation: All authors; (VI) Manuscript writing: All authors; (VII) Final  \napproval of manuscript: All authors.  \n\\#These authors contributed equally to this work.  \nCorrespondence to: Jian Peng, PhD. Anhui Institute of Pediatric Research, Anhui Provincial Children’s Hospital, No. 39 East Wangjiang Road, Hefei  \n230051, China. Email: [1518572156@qq.com](1518572156@qq.com).  \nBackground: Osteoglycin (OGN), an extracellular matrix protein, has emerging but poorly characterized roles in cancer. This study presents the first pan-cancer investigation of OGN’s expression patterns, clinical  \nsignificance, immune interactions, and functional mechanisms.  \nMethods: Multi-omics data from Genotype Tissue Expression (GTEx), Cancer Cell Line Encyclopedia (CCLE), The Cancer Genome Atlas (TCGA), and Human Protein Atlas (HPA) databases were integrated.  \nDifferential expression was analyzed in normal tissues and tumor samples. Diagnostic utility was evaluated using area under the curve (AUC) of receiver operating characteristic (ROC) curve. Prognostic value was assessed via Kaplan-Meier [overall survival (OS); disease-specific survival (DSS); disease free interval (DFI);  \nprogression-free interval (PFI)] and Cox regression analyses. Immune microenvironment correlations were quantified using ESTIMATE, CIBERSORT, and gene set enrichment. Functional pathways were explored  \nthrough gene set enrichment analysis (GSEA) and correlation with hallmark cancer signatures.  \nResults: OGN was broadly expressed in normal tissues (brain, liver, kidney) but significantly downregulated in most tumor types (P\u003C0.05, TCGA; validated at protein level, HPA) . OGN demonstrated high diagnostic accuracy in pan-cancer (AUC: 0.703–0.990), achieving near-perfect performance in colon adenocarcinoma  \n(COAD) (AUC: 0.966) and thyroid cancer (THCA) (AUC: 0.920) . High OGN expression correlated with improved survival outcomes in thymoma (THYM) (OS/DSS) and cholangiocarcinoma (CHOL) (PFI/DFI), but worse prognosis in lung adenocarcinoma/liver hepatocellular carcinoma (LUAD/LIHC), indicating cancer-type specificity. OGN expression strongly associated with immune cell infiltration (macrophages, natural killer cells, T cells), chemokine signaling, programmed death-ligand 1 (PD-L1) levels, microsatellite instability (MSI), and tumor mutation burden (TMB) . GSEA revealed enrichment of OGN-linked genes in  \nepithelial-mesenchymal transition (EMT), angiogenesis, JAK-STAT, and PI3K pathways across cancers.  \nConclusions: Our pan-cancer analysis highlights OGN as a context-dependent regulator linking extracellular matrix (ECM) remodeling with immune and angiogenic signaling. Its pan-cancer dysregulation, diagnostic/prognostic value, and crosstalk with immune evasion mechanisms nominate OGN as a promising  \nmulti-functional biomarker and therapeutic target.  \nKeywords: Osteoglycin (OGN); pan-cancer; immune microenvironment; prognosis  \nSubmitted Jul 10, 2025. Accepted for publication Nov 07, 2025. Published online Jan 27, 2026.  \ndoi: 10.21037/tcr-2025-1499  \nView this article at: [https://dx.doi.org/10.21037/tcr-2025-1499](https://dx.doi.or","cbCaiui0ll6v0lit","https://ap.wps.com/l/cbCaiui0ll6v0lit","pdf",9830006,24,"English","# Introduction\n## Background on OGN and cancer\n# Methods\n## Data integration and differential expression\n## Diagnostic and prognostic analyses\n## Immune microenvironment correlation and pathway exploration\n# Results\n## Pan-cancer expression and diagnostic accuracy\n## Prognostic associations by cancer type\n## Immune linkage and pathway enrichment\n# Conclusions","[{\"question\":\"What is the study aim regarding OGN in pan-cancer?\",\"answer\":\"To determine OGN expression patterns across cancers, evaluate diagnostic and prognostic utility, and characterize immune microenvironment interactions and functional mechanisms.\"},{\"question\":\"How is OGN diagnostic performance assessed?\",\"answer\":\"Diagnostic utility is evaluated using the area under the ROC curve (AUC), comparing normal tissues with tumor samples.\"},{\"question\":\"What immune-related features are associated with high OGN expression?\",\"answer\":\"High OGN expression correlates with immune cell infiltration, chemokine signaling, PD-L1 levels, microsatellite instability (MSI), and tumor mutation burden (TMB).\"}]","Clinical utility of OGN in pan-cancer - diagnostic biomarker and immune microenvironment regulator | PDF",1790106642,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5295fc74ff3351ad20c77a1205eacd2.webp",983,1287,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ad58f24ba09a1da7e3ff9778459cf947.webp",982,1286,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8063e979139a0606b791c647e30cfc09.webp",981,1284,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c3bd65882a055851b438b4e4fd4b5e73.webp",980,1283]